IBM open-sources 3 AI projects devoted to curing cancer artificial intelligence news. IBM gives cancer-killing drug AI project to the open source community. If we understand cancer more at the molecular level, we can learn to treat cancer more with IBM open-sources three AI projects. Checkout IBM’s multi-cloud deals.
According to news making tech headlines this week, IBM has made three AI projects aiming to help cure cancer for humans available to the open-source community.
Statistics has it that cancer is estimated to have caused an estimate of 9 million, six hundred thousand deaths last year alone. Research shows that about 1 in 2 will develop cancer in their lifetimes, and few will not know someone impacted by its blight.
For the better part, advancements are making the discovery and treatment of cancer faster, easier and even more effective. For sometime now, IBM has been working on three AI-powered projects to help tackle this global challenge on cancer.
IBM says that their goal is to deepen their understanding of cancer to equip industries and academia with the knowledge that could potentially one day help fuel new therapies and treatments.
PaccMann: Project 1
First of all, the project called, PaccMann, has a goal to use deep learning for helping to predict the efficiency of cancer-fighting drugs to humans. A lot of money in millions of dollars can be spent on getting approval for a single drug so identifying compounds likely to be most effective is vital.
- VMware & Google Cloud completes deal, as hybrid partner for hyperscalers
- Google Launches Anthos Hybrid Cloud Platform & Workload Management
- IBM Finalizes $34Billion Red Hat deal, vaults into multi-cloud
- Microsoft Launches Azure Security Center for IoT
INtERAcT – Project 2
Secondly, the tool called INtERAcT (Interaction Network infErence from vectoR representATions of words), is used for automating the extraction of knowledge from scientific publications. Also, it’s a tool anyone who spends time making research papers will understand, but very few have such importance as seeking the information to help treat cancer on earth.
A statement published by IBM paper states that “a particular strength of INtERAcT is its capability to infer interactions in the context of a specific disease. Also, the comparison with the normal interactions in healthy tissue may potentially help to obtain insight into the disease mechanisms.”
PIMKL – Project 3
Finally, the last but not least is the project called PIMKL, which aims at helping doctors predict the progression of a disease in man. Generally speaking, such a prediction helps clinicians to better personalise and design effective cancer treatments.
In conclusion, IBM open-sources three AI projects has been dedicated to curing cancer. Last week, we saw in the news where tech teams where saying that Artificial Intelligence should be recognized as an Inventor.